Responses of dog large coronary arteries to constrictor and dilator substances: implications for the cause and treatment of variant angina pectoris.
D000788:Angina Pectoris, Variant / Q000188:drug therapy* / Q000209:etiology; D000818:Animals; D001158:Arteries / Q000187:drug effects; D003251:Constriction, Pathologic; D003329:Coronary Vasospasm / Q000188:drug therapy*; D003331:Coronary Vessels / Q000187:drug effects*; D004285:Dogs; D009543:Nifedipine / Q000009:adverse effects / Q000627:therapeutic use; D005996:Nitroglycerin / Q000627:therapeutic use; D012701:Serotonin / Q000494:pharmacology; D014662:Vasoconstrictor Agents / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D014665:Vasodilator Agents / Q000494:pharmacology* / Q000627:therapeutic use; D014700:Verapamil / Q000009:adverse effects / Q000627:therapeutic use
D014662:Vasoconstrictor Agents; D014665:Vasodilator Agents; D012701:Serotonin; D014700:Verapamil; D005996:Nitroglycerin; D009543:Nifedipine